INFINITI 2C9 & VKORC1 MULTIPLEX ASSAY FOR WARFARIN

Cytochrome P450 2c9 (cyp450 2c9) Drug Metabolizing Enzyme Genotyping System

AUTOGENOMICS, INCORPORATED

The following data is part of a premarket notification filed by Autogenomics, Incorporated with the FDA for Infiniti 2c9 & Vkorc1 Multiplex Assay For Warfarin.

Pre-market Notification Details

Device IDK073014
510k NumberK073014
Device Name:INFINITI 2C9 & VKORC1 MULTIPLEX ASSAY FOR WARFARIN
ClassificationCytochrome P450 2c9 (cyp450 2c9) Drug Metabolizing Enzyme Genotyping System
Applicant AUTOGENOMICS, INCORPORATED 2251 RUTHERFORD ROAD Carlsbad,  CA  92008
ContactEvelyn G Lopez
CorrespondentEvelyn G Lopez
AUTOGENOMICS, INCORPORATED 2251 RUTHERFORD ROAD Carlsbad,  CA  92008
Product CodeODW  
Subsequent Product CodeNSU
Subsequent Product CodeODV
CFR Regulation Number862.3360 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeAbbreviated
3rd Party ReviewedNo
Combination ProductNo
Date Received2007-10-25
Decision Date2008-01-23
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00850009370181 K073014 000
00850009370174 K073014 000
00850009370167 K073014 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.